Skip to main content

Lidocaine Hcl

Brand names: Dermacinrx Lidogel, Glydo, Lidocaine Hcl, Lidocaine Hcl Viscous, Xylocaine

Antiarrhythmic, Amide Local Anesthetic, beta-Adrenergic Agonist, Catecholamine, alpha-Adrenergic Agonist

At a glance

Medicare prescriptions, 2024
171,820
Medicare drug cost
$3.1M
Average cost per prescription
$18.16
Clinicians who prescribed it
7,794

Where it is prescribed

Loading map…

List the prescribers in any state, county, city or ZIP code →

Trend, 2019–2024

Medicare prescriptions fell 4% from 2019 to 2024.

Medicare Part D prescriptions per year, all prescribers
  • 2019567,977
  • 2020559,002
  • 2021525,876
  • 2022534,634
  • 2023472,846
  • 2024547,312

Biggest change by state since 2019

  • Kentucky +17%
  • Connecticut +12%
  • Arkansas +10%
  • New York +9%
  • Florida +9%
  • Puerto Rico (smallest change) −27%
  • Colorado (smallest change) −21%

From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.

What it looks like

Pills from 1 maker on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.

The Procter & Gamble Manufacturing Company

StrengthLooks likeImprint
4 g / 1 g mentholwhite liquid

Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.

Industry payments about this drug

Drug makers reported $1,365 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).

  • Sagent Pharmaceuticals $1,365

See all companies →

Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor

Recalls and shortages

Not on the FDA drug shortage list.

1 recall since 2020

  • Nov 2020 · Mpm Medical LLC · Class I
    Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.

See all recalls →

Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)

Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.